ITGAX and neoplasm: Unlike the immune composition observed in tumor tissues, T lymphocytes were dominant in TDLN (63.6%), BM (8.03%), and spleen (66.2%), compared to CD11c+ DCs (TDLN: 0.27%; BM: 0.48%; spleen: 0.46%), CD68+ macrophages (TDLN: 0.01%; BM: 0.14%; spleen: 0.01%), and CD56+ NK cells (TDLN: 0.16%; BM: 0.25%; spleen: 0.39%) (Figures 3B–D).